Page last updated: 2024-09-02

5-hydroxydopamine and Neuroblastoma

5-hydroxydopamine has been researched along with Neuroblastoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eggert, K; Neff, F; Noelker, C; Schlegel, J1
Mazzio, E; Soliman, KF1

Other Studies

2 other study(ies) available for 5-hydroxydopamine and Neuroblastoma

ArticleYear
Signaling pathways mediate the neuroprotective effects of GDNF.
    Annals of the New York Academy of Sciences, 2002, Volume: 973

    Topics: 14-3-3 Proteins; Gene Expression Regulation, Neoplastic; Glial Cell Line-Derived Neurotrophic Factor; Humans; Hydroxydopamines; Neoplasm Proteins; Nerve Growth Factors; Neuroblastoma; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Polymerase Chain Reaction; Signal Transduction; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase

2002
Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro.
    Neuroscience letters, 2003, Feb-06, Volume: 337, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Hydrogen Peroxide; Hydroxydopamines; Neuroblastoma; Neuroprotective Agents; Parkinson Disease; Pyruvic Acid; Tumor Cells, Cultured

2003